2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trialIan Smith, Martine Piccart, A. Feyereislova et al.|The Lancet|2007Cited by 1.5k
Survey of Fertility Preservation Options Available to Patients With Cancer Around the GlobeAlexandra S. Rashedi, Rod T. Mitchell, Saskia F. de Roo et al.|JCO Global Oncology|2017Cited by 99